Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments.
Alembic Pharma shares surge 5% on USFDA product approvals on January 2, 2024 at 6:03 am
Alembic Pharma is planning to launch over 20 products in the current financial year (FY24), with a focus on oral solids, injectables, and derma segments.